Financial

Cancer diagnostics tech developer Freenome cashed in an additional $290m from returning investor Roche, which will support it as it looks to expand its products to additional cancers.

The corporate's ongoing Latin American portfolio has grown after it led pet product retailer Laika's $48m series B round and a $40m round for rural finance provider TerraMagna.

SoftBank led 5G chip developer Eigencomm's $157m series C round while smart bank Seba Bank raised $120m in its own series C, which included Alameda Research.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.

2021 registered record figures in the realm of corporate venturing.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.

Coinbase Ventures has returned to back the IRA-targeted alternatives investing scheme operator, as the unit diversifies its blockchain and crypto-themed portfolio.

The digital transformation that has disrupted and reshaped the industrial sector in recent years, known as the fourth industrial revolution or industry 4.0, has now reached a new chapter with the development of what has been dubbed as industry 5.0.